{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:34:25Z","timestamp":1790904865414,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.regpep.2009.09.009","type":"journal-article","created":{"date-parts":[[2009,10,2]],"date-time":"2009-10-02T09:02:28Z","timestamp":1254474148000},"page":"45-51","source":"Crossref","is-referenced-by-count":47,"title":["Regulatory peptides from chromogranin A and secretogranin II: Putative modulators of cells and tissues involved in inflammatory conditions"],"prefix":"10.1016","volume":"165","author":[{"given":"Karen B.","family":"Helle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2009.09.009_bb0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0968-0004(91)90012-K","article-title":"The granin (chromogranin\/secretogranin) family","volume":"16","author":"Huttner","year":"1991","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.regpep.2009.09.009_bb0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0306-4522(92)90222-N","article-title":"The chromogranins A and B: the first 25 years and future perspectives","volume":"49","author":"Winkler","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.regpep.2009.09.009_bb0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/0-306-46837-9_28","article-title":"Chromogranin A and tumor necrosis factor-alpha (TNF) in chronic heart failure","volume":"482","author":"Corti","year":"2000","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0020","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1053\/euhj.2001.2977","article-title":"Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality","volume":"23","author":"Ceconi","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.regpep.2009.09.009_bb0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/0-306-46837-9_31","article-title":"Chromogranin A in human disease","volume":"482","author":"O'Connor","year":"2000","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0030","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1196\/annals.1351.041","article-title":"Neuroendocrine modulation induced by selective blockade of TNF-alpha in rheumatoid arthritis","volume":"1069","author":"Di Comite","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.regpep.2009.09.009_bb0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1189\/jlb.0608358","article-title":"Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF-{alpha}-elicited endothelial activation","volume":"85","author":"Di Comite","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0040","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1373\/clinchem.2007.102442","article-title":"Prognostic value of chromogranin A at admission in critically ill patients: a cohort study in a medical intensive care unit","volume":"54","author":"Zhang","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.regpep.2009.09.009_bb0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-5793(91)80754-Q","article-title":"Identification of a peptide arising from the specific post-translation processing of secretogranin II","volume":"284","author":"Vaudry","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1016\/j.regpep.2009.09.009_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0167-0115(02)00161-1","article-title":"The neuropeptide secretoneurin stimulates adhesion of human monocytes to arterial and venous endothelial cells in vitro","volume":"110","author":"K\u00e4hler","year":"2002","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2009.09.009_bb0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0167-0115(01)00379-2","article-title":"Transendothelial migration of leukocytes and signalling mechanisms in response to the neuropeptide secretoneurin","volume":"105","author":"K\u00e4hler","year":"2002","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2009.09.009_bb0060","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0306-4522(96)83172-1","article-title":"Chromogranin A triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells","volume":"72","author":"Taupenot","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.regpep.2009.09.009_bb0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/0-306-46837-9_23","article-title":"Chromogranin A induces a neurotoxic phenotype in brain microglial cells","volume":"482","author":"Ciesielski-Treska","year":"2000","journal-title":"Adv Exp Mol Biol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neulet.2006.11.068","article-title":"Chromogranin A activates diverse pathways mediating inducible nitric oxide expression and apoptosis in primary microglia","volume":"413","author":"Hooper","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.regpep.2009.09.009_bb0075","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.lfs.2004.02.035","article-title":"The effect of a chromogranin A-derived peptide (CgA4\u201316) in the writhing nociceptive induced by acetic acids in rats","volume":"75","author":"Ghia","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.regpep.2009.09.009_bb0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.regpep.2004.04.003","article-title":"A role for chromogranin A (4\u201316), a vasostatin-derived peptide, on human colonic motility. An in vitro study","volume":"121","author":"Ghia","year":"2004","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2009.09.009_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.regpep.2004.06.022","article-title":"Effect of acetic acid or trypsin application on rat colonic motility in vitro and modulation by two synthetic fragments of chromogranin A","volume":"124","author":"Ghia","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2009.09.009_bb0090","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1096\/fj.03-0922fje","article-title":"Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage","volume":"18","author":"Ferrero","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.regpep.2009.09.009_bb0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.regpep.2006.04.007","article-title":"The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells","volume":"135","author":"Blois","year":"2006","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2009.09.009_bb0100","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1096\/fj.06-6829com","article-title":"The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration","volume":"21","author":"Belloni","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.regpep.2009.09.009_bb0105","unstructured":"Helle KB. Chromogranins A and B and secretogranin II as prohormones for regulatory peptides from the diffuse neuroendocrine system. In Cellular Peptide Hormone Synthesis and Secretory Pathways (Eds. Rehfeld JF and Bundgaard JR), Springer Press, Heidelberg, Germany, in press."},{"key":"10.1016\/j.regpep.2009.09.009_bb0110","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0196-9781(98)00086-2","article-title":"Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo","volume":"19","author":"Kennedy","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.regpep.2009.09.009_bb0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0167-0115(03)00069-7","article-title":"Catestatin (CgA344\u2013364) stimulates rat mast cell release of histamine in a manner comparable to mastoparan and other cationic charged neuropeptides","volume":"114","author":"Kr\u0171ger","year":"2003","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2009.09.009_bb0120","doi-asserted-by":"crossref","first-page":"10745","DOI":"10.1074\/jbc.275.15.10745","article-title":"Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A","volume":"275","author":"Lugardon","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2009.09.009_bb0125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00018-004-4461-9","article-title":"New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A","volume":"62","author":"Briolat","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.regpep.2009.09.009_bb0130","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/eurheartj\/ehm022","article-title":"Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function","volume":"28","author":"Pieroni","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.regpep.2009.09.009_bb0135","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0016-5085(95)90693-2","article-title":"Circulating pancreastatin is a marker for the enterochromaffin-like cells of the rat stomach","volume":"108","author":"H\u00e5kanson","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.regpep.2009.09.009_bb0140","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1200\/JCO.1995.13.3.681","article-title":"Plasma chromogranin A: a marker of serotonin release and of emesis associated with cisplatin chemotherapy","volume":"13","author":"Cubeddu","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0145","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0306-4522(93)90146-7","article-title":"Chromogranin A immunoreactivity in human cerebrospinal fluid: properties, relationship to noradrenergic neuronal activity and variation in neurological disease","volume":"56","author":"O'Connor","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.regpep.2009.09.009_bb0150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0306-4522(93)90200-Y","article-title":"Secretoneurin \u2014 a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C)","volume":"53","author":"Kirchmair","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.regpep.2009.09.009_bb0155","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0022-5347(05)67714-2","article-title":"Elevated levels of serum secretoneurin in patients with therapy resistant carcinoma of the prostate","volume":"163","author":"Ischia","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0160","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1373\/clinchem.2006.076158","article-title":"Processing-independent quantitation of chromogranin A in plasma from patients with neuroendocrine tumors and small-cell lung carcinomas","volume":"53","author":"B\u00f8rglum","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.regpep.2009.09.009_bb0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/01.HYP.26.1.213","article-title":"Chromogranin A in human hypertension. Influence of heredity","volume":"26","author":"Takiyyuddin","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.regpep.2009.09.009_bb0170","first-page":"25","article-title":"Prognostic value of circulating chromogranin A levels in acute coronary syndromes","volume":"36","author":"Jansson","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.regpep.2009.09.009_bb0175","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0196-9781(00)00271-0","article-title":"Secretoneurin: a functional neuropeptide in health and disease","volume":"21","author":"Wiedermann","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.regpep.2009.09.009_bb0180","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/0-306-46837-9_22","article-title":"Secretoneurin \u2014 a novel link between the nervous and the immune system","volume":"482","author":"K\u00e4hler","year":"2000","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0185","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/324476a0","article-title":"Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion","volume":"324","author":"Tatemoto","year":"1986","journal-title":"Nature (Lond)"},{"key":"10.1016\/j.regpep.2009.09.009_bb0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2826.1993.tb00501.x","article-title":"Vasostatins, comprising the N-terminal domains of chromogranin A, suppress tension in isolated human blood vessel segments","volume":"5","author":"Aardal","year":"1993","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0195","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1210\/en.135.1.337","article-title":"Stimulation of parathyroid hormone secretion by low calcium is inhibited by amino terminal chromogranin peptides","volume":"135","author":"Russell","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2009.09.009_bb0200","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1172\/JCI119686","article-title":"Novel autocrine feedback control of catecholamine release. A discrete chromogranin A fragment is a noncompetitive nicotinic cholinergic antagonist","volume":"100","author":"Mahata","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.regpep.2009.09.009_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(93)90377-R","article-title":"Secretoneurin releases dopamine from rat striatal slices: a biological effect of a peptide derived from secretogranin II (chromogranin C)","volume":"54","author":"Saria","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.regpep.2009.09.009_bb0210","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1017\/S146479310400644X","article-title":"The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects","volume":"79","author":"Helle","year":"2004","journal-title":"Biol Rev (Cambr)"},{"key":"10.1016\/j.regpep.2009.09.009_bb0215","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1007\/s00018-007-7254-0","article-title":"The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties","volume":"64","author":"Helle","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.regpep.2009.09.009_bb0220","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1210\/en.137.7.2918","article-title":"Determination of residues in chromogranin A (16\u201340) required for inhibition of parathyroid hormone secretion","volume":"137","author":"Angeletti","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2009.09.009_bb0225","doi-asserted-by":"crossref","first-page":"35875","DOI":"10.1074\/jbc.M104670200","article-title":"Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47\u201366)-derived peptide","volume":"276","author":"Lugardon","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2009.09.009_bb0230","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00249-007-0169-8","article-title":"Variability in secondary structure of the antimicrobial peptide cateslytin in powder, solution, DPC micelles and at the air\u2013water interface","volume":"36","author":"Jean-Fran\u00e7ois","year":"2007","journal-title":"Eur Biophys J"},{"key":"10.1016\/j.regpep.2009.09.009_bb0235","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1210\/en.2007-0838","article-title":"Proteolytic cleavage of human chromogranin A containing catestatin variants: different processing at catestatin region by plasmin","volume":"149","author":"Biswas","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2009.09.009_bb0240","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1432-1033.1997.00665.x","article-title":"A determination of the solution conformation of secretoneurin, a neuropeptide originating from the processing of secretogranin II, by 1H-NMR and restrained molecular dynamics","volume":"246","author":"Oulyadi","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.regpep.2009.09.009_bb0245","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0167-0115(92)90509-S","article-title":"The vasoinhibitory activity of bovine chromogranin A fragments (vasostatins) and its independence of extracellular calcium in isolated segments of human blood vessels","volume":"41","author":"Aardal","year":"1992","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2009.09.009_bb0250","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1677\/joe.0.1650703","article-title":"Characterization of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods","volume":"165","author":"Stridsberg","year":"2000","journal-title":"J Endocrinol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0255","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-5793(88)80036-X","article-title":"The molecular cloning of the chromogranin A-like precursor of beta-granin and pancreastatin from the endocrine pancreas","volume":"236","author":"Hutton","year":"1988","journal-title":"FEBS Lett"},{"key":"10.1016\/j.regpep.2009.09.009_bb0260","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1111\/j.1742-4658.2006.05334.x","article-title":"Characterization of natural vasostatin-containing peptides in rat heart","volume":"273","author":"Glattard","year":"2006","journal-title":"FEBS J"},{"key":"10.1016\/j.regpep.2009.09.009_bb0265","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.regpep.2005.11.003","article-title":"Interaction of chromogranin A-derived vasostatins and monolayers of phosphatidyl serine, phosphatidyl choline and phosphatidyl ethanolamine","volume":"134","author":"Blois","year":"2006","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2009.09.009_bb0270","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cvr\/cvn155","article-title":"Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure","volume":"80","author":"Mahapatra","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.regpep.2009.09.009_bb0275","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1748-1716.2007.01806.x","article-title":"Chromogranins A and B and secretogranin II: evolutionary and functional aspects","volume":"192","author":"Montero-Hadjadje","year":"2008","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.regpep.2009.09.009_bb0280","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1460-9568.1993.tb00227.x","article-title":"Distribution of secretoneurin-like immunoreactivity in comparison with substance P- and enkephalin-like immunoreactivities in various human forebrain regions","volume":"5","author":"Marksteiner","year":"1993","journal-title":"Eur J NeuroSci"},{"key":"10.1016\/j.regpep.2009.09.009_bb0285","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0301-0082(94)00060-U","article-title":"Secretogranin II: molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin","volume":"46","author":"Fischer-Colbrie","year":"1995","journal-title":"Progr Neurobiol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0290","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF01464781","article-title":"Secretoneurin: a new peptide in the human enteric nervous system","volume":"104","author":"Sch\u00fcrmann","year":"1995","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0295","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0891-0618(95)00066-G","article-title":"Secretoneurin-immunoreactivity in nerve terminals opposing identified preganglionic sympathetic neurons in the rat: co-localization with substance P and enkephalin","volume":"9","author":"Klimaschewski","year":"1995","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.regpep.2009.09.009_bb0300","doi-asserted-by":"crossref","first-page":"14339","DOI":"10.1074\/jbc.273.23.14339","article-title":"Chromogranin A induces a neurotoxic phenotype in brain microglial cells","volume":"273","author":"Ciesielski-Treska","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2009.09.009_bb0305","doi-asserted-by":"crossref","first-page":"13113","DOI":"10.1074\/jbc.M009711200","article-title":"Mechanisms underlying neuronal death induced by chromogranin A-activated microglia","volume":"276","author":"Ciesielski-Treska","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2009.09.009_bb0310","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1046\/j.1471-4159.2000.0741452.x","article-title":"Microglial apoptosis induced by chromogranin A is mediated by mitochondrial depolarisation and the permeability transition but not by cytochrome c release","volume":"74","author":"Kingham","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.regpep.2009.09.009_bb0315","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.regpep.2005.03.004","article-title":"Inhibitory influence of chromogranin A N-terminal fragment (vasostatin-I) on the spontaneous contractions of rat proximal colon","volume":"130","author":"Amato","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2009.09.009_bb0320","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2174\/138920306779025585","article-title":"Biochemical applications of the receptor-mimetic peptide mastoparan","volume":"7","author":"Jones","year":"2006","journal-title":"Curr Prot Pept Sci"},{"key":"10.1016\/j.regpep.2009.09.009_bb0325","article-title":"The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular functions","author":"Helle","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.regpep.2009.09.009_bb0330","doi-asserted-by":"crossref","first-page":"e 4501","DOI":"10.1371\/journal.pone.0004501","article-title":"Two antimicrobial chromogranin A-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2","volume":"4","author":"Zhang","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.regpep.2009.09.009_bb0335","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/j.semnuclmed.2008.10.004","article-title":"Cardiovascular infection and inflammation","volume":"39","author":"Ben-Haim","year":"2009","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.regpep.2009.09.009_bb0340","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MCA.0b013e3282fc617c","article-title":"Plasma levels of TNF-alpha, IL-6, and IL-10 and their relationship with left ventricular diastolic function in patients with stable angina pectoris and preserved left ventricular systolic performance","volume":"19","author":"Kosmala","year":"2008","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.regpep.2009.09.009_bb0345","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00380-008-1080-7","article-title":"Chronic systemic inflammation accompanies impaired ventricular diastolic function, detected by Doppler imaging, in patients with newly diagnosed systolic heart failure (Hellenic Heart Failure Study)","volume":"24","author":"Chrysohoou","year":"2009","journal-title":"Heart Vessels"},{"key":"10.1016\/j.regpep.2009.09.009_bb0350","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2362.2008.02056.x","article-title":"Elevated VEGF-plasma levels in young patients with mild essential hypertension","volume":"39","author":"Stumpf","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.regpep.2009.09.009_bb0355","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1291\/hypres.31.2137","article-title":"Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension","volume":"31","author":"Tatasciore","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1016\/j.regpep.2009.09.009_bb0360","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1253\/circj.72.293","article-title":"Association between blood pressure variability and inflammatory marker in hypertensive patients","volume":"72","author":"Kim","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.regpep.2009.09.009_bb0365","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.jhh.1001785","article-title":"Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension","volume":"19","author":"Bautista","year":"2005","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.regpep.2009.09.009_bb0370","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1089\/ars.2007.1998","article-title":"Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension","volume":"10","author":"Watson","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.regpep.2009.09.009_bb0375","article-title":"Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage\/dysfunction","author":"Foster","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.regpep.2009.09.009_bb0380","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/1753944708093412","article-title":"Endothelial progenitor cells: markers of vascular reparative capacity","volume":"2","author":"Povsic","year":"2008","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.regpep.2009.09.009_bb0385","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.surg.2006.04.001","article-title":"Secretoneurin increases monolayer permeability in human coronary artery endothelial cells","volume":"140","author":"Yan","year":"2006","journal-title":"Surgery"},{"key":"10.1016\/j.regpep.2009.09.009_bb0390","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0014-5793(93)81676-Q","article-title":"Attraction of human monocytes by the neuropeptide secretoneurin","volume":"334","author":"Reinich","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1016\/j.regpep.2009.09.009_bb0395","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0014-2999(98)00814-0","article-title":"A soluble gradient of the neuropeptide secretoneurin promotes the transendothelial migration of monocytes in vitro","volume":"365","author":"K\u00e4hler","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0400","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1749-6632.2002.tb04497.x","article-title":"Vasostatins exert negative inotropism in the working heart of the frog","volume":"971","author":"Corti","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.regpep.2009.09.009_bb0405","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ygcen.2003.12.012","article-title":"Chromogranin A N-terminal fragments vasostatin-1 and the synthetic CGA 7\u201357 peptide acts as cardiostatins on the isolating working frog heart","volume":"136","author":"Corti","year":"2004","journal-title":"Gen Comp Endocrinol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0410","doi-asserted-by":"crossref","first-page":"H113","DOI":"10.1152\/ajpheart.00172.2008","article-title":"Catestatin (chromogranin A344\u2013364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart","volume":"295","author":"Mazza","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0415","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00395-005-0547-2","article-title":"Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart","volume":"101","author":"Cerra","year":"2006","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0420","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1096\/fj.08-110239","article-title":"The homologous rat Chromogranin A1\u201364 (rCGA1\u201364) modulates myocardial and coronary function in the rat heart counteracting the adrenergic stimulation through endothelium-derived nitric oxide mechanisms","volume":"22","author":"Cerra","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.regpep.2009.09.009_bb0425","doi-asserted-by":"crossref","first-page":"H719","DOI":"10.1152\/ajpheart.01352.2006","article-title":"Human recombinant chromogranin A-derived vasostatin1 mimics preconditioning via an adenosine\/nitric oxide signalling mechanism","volume":"293","author":"Cappello","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0430","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1210\/en.2008-0318","article-title":"The antihypertensive chromogranin A peptide catestatin acts as a novel endocrine\/paracrine modulator of cardiac inotropism and lucitropism","volume":"149","author":"Angelone","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2009.09.009_bb0435","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ygcen.2004.07.008","article-title":"Influence of vasostatins, the chromogranin A-derived peptides, on the working heart of the eel (Anguilla anguilla): negative inotropy and mechanism of action","volume":"139","author":"Imbrogno","year":"2004","journal-title":"Gen Comp Endocrinol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0440","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-0115(03)00112-5","article-title":"Peptides from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in the isolated frog heart","volume":"114","author":"Tota","year":"2003","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2009.09.009_bb0445","doi-asserted-by":"crossref","first-page":"20835","DOI":"10.1074\/jbc.272.33.20835","article-title":"Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain","volume":"272","author":"Gasparri","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2009.09.009_bb0450","doi-asserted-by":"crossref","first-page":"29257","DOI":"10.1074\/jbc.M003796200","article-title":"Structure\u2013activity relationships of chromogranin A in cell adhesion. Identification of an adhesion site for fibroblasts and smooth muscle cells","volume":"275","author":"Ratti","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2009.09.009_bb0455","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejphar.2008.09.016","article-title":"Monocyte migration: a novel effect and signalling pathways of catestatin","volume":"598","author":"Egger","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0460","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.ATV.17.5.932","article-title":"Inhibition of proliferation and stimulation of migration of endothelial cells by secretoneurin in vitro","volume":"17","author":"K\u00e4hler","year":"1997","journal-title":"Arteroscler Thromb Vasc Biol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0465","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/01.ATV.17.10.2029","article-title":"Response of vascular smooth muscle cells to the neuropeptide secretoneurin. A functional role for migration and proliferation in vitro","volume":"17","author":"K\u00e4hler","year":"1997","journal-title":"Arteroscler Thromb Vasc Biol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0470","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0167-0115(96)00009-2","article-title":"Deactivation of chemotaxis of human neutrophils by priming with secretogranin II-derived secretoneurin","volume":"63","author":"Schratzberger","year":"1996","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2009.09.009_bb0475","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-5728(98)00094-0","article-title":"Secretoneurin and chemoattractant receptor interactions","volume":"88","author":"Kong","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0480","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/01.CIR.0000112574.07422.C1","article-title":"The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo","volume":"109","author":"Kirchmair","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2009.09.009_bb0485","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/01.CIR.0000139884.81390.56","article-title":"Secretoneurin, an angiogenic neuropeptide, induces postnatal vasculogenesis","volume":"110","author":"Kirchmair","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2009.09.009_bb0490","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1096\/fj.06-7440com","article-title":"Hypoxia up-regulates the angiogenic cytokine secretoneurin via and HIF-1\u03b1- and basic FGF-dependent pathway in muscle cells","volume":"21","author":"Egger","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.regpep.2009.09.009_bb0495","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/1389203054546334","article-title":"Secretoneurin: a new player in angiogenesis and chemotaxis linking nerves, blood vessels and the immune system","volume":"6","author":"Fischer-Colbrie","year":"2005","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.regpep.2009.09.009_bb0500","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1172\/JCI32723","article-title":"Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2\/Stat3 pathway in murine models of stroke","volume":"118","author":"Shyu","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.regpep.2009.09.009_bb0505","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/A:1022573004910","article-title":"Antibacterial peptides are present in chromaffin cell secretory granules","volume":"18","author":"Metz-Boutigue","year":"1998","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0510","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/sj.jid.5701225","article-title":"The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury","volume":"128","author":"Radek","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0515","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1748-1716.1994.tb09780.x","article-title":"Vasoinhibitory activity of the synthetic peptides from the amino terminus of the adrenomedullary chromogranin A","volume":"152","author":"Angeletti","year":"1994","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.regpep.2009.09.009_bb0520","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-5728(98)00012-5","article-title":"Specific binding of a 125I-secretoneurin analogue to a human monocyte cell line","volume":"86","author":"Schneitler","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.regpep.2009.09.009_bb0525","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/080370599439508","article-title":"Catecholamine storage vesicle protein expression in genetic hypertension","volume":"8","author":"O'Connor","year":"1999","journal-title":"Blood Press"},{"key":"10.1016\/j.regpep.2009.09.009_bb0530","doi-asserted-by":"crossref","first-page":"45911","DOI":"10.1074\/jbc.M202637200","article-title":"Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion","volume":"277","author":"Colombo","year":"2002","journal-title":"J Biol Chem"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011509002031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011509002031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:20:37Z","timestamp":1558570837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011509002031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0167011509002031"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2009.09.009","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}